Patrick Burnett - 02 Jan 2024 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
Reporting Person's title: Senior Vice President, Chief Medical Officer
Signature
/s/ John W. Smither, as Attorney-in-Fact for Patrick Burnett
Issuer symbol
ARQT
Transactions as of
02 Jan 2024
Net transactions value
-$4,692
Form type
4
Filing time
03 Jan 2024, 17:30:56 UTC
Previous filing
22 Aug 2023
Next filing
17 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARQT Common Stock Sale $4,692 -1,325 -2.3% $3.54 57,032 02 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units ("RSUs"), granted on August 3, 2020. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Remarks:

Reporting Person's title: Senior Vice President, Chief Medical Officer